Adult: 5 mg once daily. Patients with intermittent allergic rhinitis must be managed according to the evaluation of disease history, treatment may be discontinued after the symptoms are resolved and reinitiated upon reappearance; in case of persistent allergic rhinitis, continuous treatment may be considered during the periods of allergen exposure. Treatment recommendations may vary among countries and individual products (refer to specific product guidelines).
Child: 1-5 years As oral solution or syrup: 1.25 mg once daily; 6-11 years As orodispersible tab, oral solution or syrup: 2.5 mg once daily; ≥12 years Same as adult dose.